{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:44Z","timestamp":1753891184275,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00089","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T03:41:27Z","timestamp":1500867687000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune Thrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis"],"prefix":"10.3389","volume":"4","author":[{"given":"Despoina","family":"Dimopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Dimosiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eudokia","family":"Mandala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaxandros","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1598","DOI":"10.1097\/MD.0000000000001598","article-title":"Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura","volume":"94","author":"Roriz","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/asheducation-2015.1.631","article-title":"What\u2019s new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura","volume":"2015","author":"Sadler","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1182\/blood-2014-11-551580","article-title":"How I treat refractory thrombotic thrombocytopenic purpura","volume":"125","author":"Sayani","year":"2015","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JBM.S46458","article-title":"Management of thrombotic thrombocytopenic purpura: current perspectives","volume":"5","author":"Blombery","year":"2014","journal-title":"J Blood Med"},{"key":"B5","first-page":"12","article-title":"Thrombotic thrombopenic purpura \u2013 an unusual manifestation of rheumatic diseases","volume":"26","author":"Sakkas","year":"2015","journal-title":"Mediterr J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1182\/blood-2014-01-549469","article-title":"TTP and pregnancy","volume":"123","author":"Battinelli","year":"2014","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1111\/j.1537-2995.2012.03646.x","article-title":"Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome, 1996-2011","volume":"52","author":"Som","year":"2012","journal-title":"Transfusion"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1182\/blood-2014-10-559211","article-title":"The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura","volume":"125","author":"Lim","year":"2015","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1160\/TH08-12-0825","article-title":"Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases","volume":"102","author":"Matsuyama","year":"2009","journal-title":"Thromb Haemost"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000608","article-title":"A rare combination of thrombotic thrombocytopenic purpura and antiphospholipid syndrome","author":"Viner","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5387\/fms.59.49","article-title":"Two cases of mixed connective tissue disease complicated with thrombotic thrombocytopenic purpura","volume":"59","author":"Suzuki","year":"2013","journal-title":"Fukushima J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13023-014-0193-6","article-title":"Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study","volume":"9","author":"Ferrari","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/bjh.12718","article-title":"How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome","volume":"164","author":"Scully","year":"2014","journal-title":"Br J Haematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.12669\/pjms.326.11274","article-title":"Thrombotic thrombocytopenic purpura \u2013 analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia","volume":"32","author":"Iqbal","year":"2016","journal-title":"Pak J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3949\/ccjm.83a.15009","article-title":"Thrombotic thrombocytopenic purpura: the role of ADAMTS13","volume":"83","author":"Rogers","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000381868","article-title":"Idiopathic relapsing thrombotic thrombocytopenic purpura with persistent ADAMTS13 inhibitor activity treated sequentially with plasmapheresis, rituximab, cyclophosphamide and splenectomy","volume":"8","author":"Musa","year":"2015","journal-title":"Case Rep Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1182\/blood-2013-11-538900","article-title":"Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura","volume":"123","author":"Jiang","year":"2014","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.lpm.2007.05.045","article-title":"Thrombocytopenia during pregnancy: from etiologic diagnosis to therapeutic management","volume":"37","author":"Federici","year":"2008","journal-title":"Presse Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.11604\/pamj.2014.17.255.2940","article-title":"Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome and pregnancy","volume":"17","author":"Mwita","year":"2014","journal-title":"Pan Afr Med J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-0032-1305799","article-title":"Management of thrombotic thrombocytopenic purpura with autoantibodies to ADAMTS-13 and concurrent preeclampsia in pregnancy: multidisciplinary team approach","volume":"2","author":"Patrick","year":"2012","journal-title":"AJP Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bjh.12718","article-title":"Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura","volume":"87","author":"George","year":"2012","journal-title":"Am J Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/CMBD.S25326","article-title":"Efficacy and safety of rituximab for refractory and relapsing thrombotic thrombocytopenic purpura: a cohort of 10 cases","volume":"8","author":"Omri","year":"2015","journal-title":"Clin Med Insights Blood Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2017.1282599","article-title":"Severe antiphospholipid antibody syndrome \u2013 response to plasmapheresis and rituximab","volume":"1","author":"Gkogkolou","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"B26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrrheum.2016.191","article-title":"Systemic lupus erythematosus: extent and patterns of off-label use of rituximab for SLE","volume":"12","author":"Sanz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1182\/blood-2014-01-550244","article-title":"Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura","volume":"124","author":"Hie","year":"2014","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","article-title":"Rituximab in the treatment of autoimmune haematological disorders","volume":"141","author":"Garvey","year":"2008","journal-title":"Br J Haematol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1182\/blood-2015-01-622555","article-title":"ITP and TTP: interpreting evidence in light of patient values","volume":"125","author":"Cuker","year":"2015","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/ATVBAHA.115.306014","article-title":"Potential for recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura","volume":"35","author":"Tersteeg","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jca.21302","article-title":"Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management and future research","volume":"29","author":"Sarode","year":"2014","journal-title":"J Clin Apher"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T03:41:29Z","timestamp":1500867689000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":31,"alternative-id":["10.3389\/fmed.2017.00089"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00089","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"article-number":"89"}}